APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Meropenem Injection Market Analysis and Forecast 2026-2032

2 January 2026201 pages

Choose your research edition.

Industry ResearchMeropenem Injection Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Injection Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Meropenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Injection Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Meropenem Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Meropenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Meropenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Meropenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Meropenem Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Meropenem Injection include Chongqin Shenghuaxi, Zhejiang Hisun Pharmaceutical, Xinya Pharm, CSPC Group, Shenzhen Haibin Pharmaceutical, Sandoz, Mylan, Luoxin Pharmaceutical and United Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Meropenem Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Meropenem Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Meropenem Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Meropenem Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Meropenem Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Meropenem Injection sales, projected growth trends, production technology, application and end-user industry.

Meropenem Injection Segment by Company

Chongqin Shenghuaxi

Zhejiang Hisun Pharmaceutical

Xinya Pharm

CSPC Group

Shenzhen Haibin Pharmaceutical

Sandoz

Mylan

Luoxin Pharmaceutical

United Laboratories

Pfizer

Hainan Haiyao Co., Ltd.

Fresenius Kabi

PKU HealthCare

Sumitomo Dainippon Pharma

Sagent Pharmaceuticals

Macleods Pharmaceuticals

Johnlee Pharmaceuticals

Bionova Scientific

AuroMedics

Amneal Pharmaceuticals

Meropenem Injection Segment by Type

0.25g/vial

0.5g/vial

1g/vial

Meropenem Injection Segment by Application

Hospital

Clinics

Others

Meropenem Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Meropenem Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Meropenem Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meropenem Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Meropenem Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.25g/vial Major Manufacturers Table 3. 0.5g/vial Major Manufacturers Table 4. 1g/vial Major Manufacturers Table 5. Global Meropenem Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Others Major Manufacturers Table 9. Meropenem Injection Industry Trends Table 10. Meropenem Injection Industry Drivers Table 11. Meropenem Injection Industry Opportunities and Challenges Table 12. Meropenem Injection Industry Restraints Table 13. Global Meropenem Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Meropenem Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Meropenem Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Meropenem Injection Revenue Market Share by Region (2021-2026) Table 17. Global Meropenem Injection Revenue Market Share by Region (2027-2032) Table 18. Global Meropenem Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Meropenem Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Meropenem Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Meropenem Injection Sales Market Share by Region (2021-2026) Table 22. Global Meropenem Injection Sales Market Share by Region (2027-2032) Table 23. Global Meropenem Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Meropenem Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Meropenem Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Meropenem Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Meropenem Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Meropenem Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Meropenem Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Meropenem Injection Manufacturers, Product Type & Application Table 31. Global Meropenem Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Meropenem Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Meropenem Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Meropenem Injection Revenue Market Share by Type (2021-2026) Table 38. Global Meropenem Injection Revenue Market Share by Type (2027-2032) Table 39. Global Meropenem Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Meropenem Injection Sales Market Share by Type (2021-2026) Table 43. Global Meropenem Injection Sales Market Share by Type (2027-2032) Table 44. Global Meropenem Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Meropenem Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Meropenem Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Meropenem Injection Revenue Market Share by Application (2021-2026) Table 50. Global Meropenem Injection Revenue Market Share by Application (2027-2032) Table 51. Global Meropenem Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Meropenem Injection Sales Market Share by Application (2021-2026) Table 55. Global Meropenem Injection Sales Market Share by Application (2027-2032) Table 56. Global Meropenem Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Meropenem Injection Price by Application (2027-2032) & (US$/Unit) Table 58. Chongqin Shenghuaxi Company Information Table 59. Chongqin Shenghuaxi Business Overview Table 60. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Chongqin Shenghuaxi Meropenem Injection Product Portfolio Table 62. Chongqin Shenghuaxi Recent Development Table 63. Zhejiang Hisun Pharmaceutical Company Information Table 64. Zhejiang Hisun Pharmaceutical Business Overview Table 65. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio Table 67. Zhejiang Hisun Pharmaceutical Recent Development Table 68. Xinya Pharm Company Information Table 69. Xinya Pharm Business Overview Table 70. Xinya Pharm Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Xinya Pharm Meropenem Injection Product Portfolio Table 72. Xinya Pharm Recent Development Table 73. CSPC Group Company Information Table 74. CSPC Group Business Overview Table 75. CSPC Group Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. CSPC Group Meropenem Injection Product Portfolio Table 77. CSPC Group Recent Development Table 78. Shenzhen Haibin Pharmaceutical Company Information Table 79. Shenzhen Haibin Pharmaceutical Business Overview Table 80. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio Table 82. Shenzhen Haibin Pharmaceutical Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sandoz Meropenem Injection Product Portfolio Table 87. Sandoz Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Meropenem Injection Product Portfolio Table 92. Mylan Recent Development Table 93. Luoxin Pharmaceutical Company Information Table 94. Luoxin Pharmaceutical Business Overview Table 95. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Luoxin Pharmaceutical Meropenem Injection Product Portfolio Table 97. Luoxin Pharmaceutical Recent Development Table 98. United Laboratories Company Information Table 99. United Laboratories Business Overview Table 100. United Laboratories Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. United Laboratories Meropenem Injection Product Portfolio Table 102. United Laboratories Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Meropenem Injection Product Portfolio Table 107. Pfizer Recent Development Table 108. Hainan Haiyao Co., Ltd. Company Information Table 109. Hainan Haiyao Co., Ltd. Business Overview Table 110. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio Table 112. Hainan Haiyao Co., Ltd. Recent Development Table 113. Fresenius Kabi Company Information Table 114. Fresenius Kabi Business Overview Table 115. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Fresenius Kabi Meropenem Injection Product Portfolio Table 117. Fresenius Kabi Recent Development Table 118. PKU HealthCare Company Information Table 119. PKU HealthCare Business Overview Table 120. PKU HealthCare Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. PKU HealthCare Meropenem Injection Product Portfolio Table 122. PKU HealthCare Recent Development Table 123. Sumitomo Dainippon Pharma Company Information Table 124. Sumitomo Dainippon Pharma Business Overview Table 125. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio Table 127. Sumitomo Dainippon Pharma Recent Development Table 128. Sagent Pharmaceuticals Company Information Table 129. Sagent Pharmaceuticals Business Overview Table 130. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Sagent Pharmaceuticals Meropenem Injection Product Portfolio Table 132. Sagent Pharmaceuticals Recent Development Table 133. Macleods Pharmaceuticals Company Information Table 134. Macleods Pharmaceuticals Business Overview Table 135. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Macleods Pharmaceuticals Meropenem Injection Product Portfolio Table 137. Macleods Pharmaceuticals Recent Development Table 138. Johnlee Pharmaceuticals Company Information Table 139. Johnlee Pharmaceuticals Business Overview Table 140. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Johnlee Pharmaceuticals Meropenem Injection Product Portfolio Table 142. Johnlee Pharmaceuticals Recent Development Table 143. Bionova Scientific Company Information Table 144. Bionova Scientific Business Overview Table 145. Bionova Scientific Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Bionova Scientific Meropenem Injection Product Portfolio Table 147. Bionova Scientific Recent Development Table 148. AuroMedics Company Information Table 149. AuroMedics Business Overview Table 150. AuroMedics Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. AuroMedics Meropenem Injection Product Portfolio Table 152. AuroMedics Recent Development Table 153. Amneal Pharmaceuticals Company Information Table 154. Amneal Pharmaceuticals Business Overview Table 155. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Amneal Pharmaceuticals Meropenem Injection Product Portfolio Table 157. Amneal Pharmaceuticals Recent Development Table 158. North America Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 161. North America Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 162. North America Meropenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 163. North America Meropenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 164. North America Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 167. North America Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 168. North America Meropenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 169. North America Meropenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 170. North America Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Meropenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Meropenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Meropenem Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. North America Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 175. North America Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 176. North America Meropenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 177. North America Meropenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 178. United States Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 179. Canada Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 180. Europe Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 183. Europe Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 184. Europe Meropenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 185. Europe Meropenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 186. Europe Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 189. Europe Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 190. Europe Meropenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 191. Europe Meropenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Europe Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Meropenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Meropenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Meropenem Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. Europe Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 197. Europe Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 198. Europe Meropenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 199. Europe Meropenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Germany Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 201. France Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 202. U.K. Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 203. Italy Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 204. Netherlands Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 205. Nordic Countries Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 206. China Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 207. China Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 208. China Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 209. China Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 210. China Meropenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 211. China Meropenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 212. China Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 213. China Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 214. China Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 215. China Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 216. China Meropenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 217. China Meropenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 219. Asia Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 220. Asia Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 221. Asia Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 222. Asia Meropenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 223. Asia Meropenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 224. Asia Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 225. Asia Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 226. Asia Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 227. Asia Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 228. Asia Meropenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 229. Asia Meropenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 230. Asia Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Asia Meropenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Asia Meropenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Asia Meropenem Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. Asia Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 235. Asia Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 236. Asia Meropenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 237. Asia Meropenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Japan Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 239. South Korea Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 240. India Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 241. Australia Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 242. China Taiwan Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 243. Southeast Asia Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 244. SAMEA Meropenem Injection Revenue by Type (2021-2026) & (US$ Million) Table 245. SAMEA Meropenem Injection Revenue by Type (2027-2032) & (US$ Million) Table 246. SAMEA Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 247. SAMEA Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 248. SAMEA Meropenem Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 249. SAMEA Meropenem Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 250. SAMEA Meropenem Injection Revenue by Application (2021-2026) & (US$ Million) Table 251. SAMEA Meropenem Injection Revenue by Application (2027-2032) & (US$ Million) Table 252. SAMEA Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 253. SAMEA Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 254. SAMEA Meropenem Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 255. SAMEA Meropenem Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 256. SAMEA Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Meropenem Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. SAMEA Meropenem Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. SAMEA Meropenem Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 260. SAMEA Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 261. SAMEA Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 262. SAMEA Meropenem Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 263. SAMEA Meropenem Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 264. Brazil Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 265. Argentina Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 266. Chile Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 267. Colombia Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 268. Peru Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 269. Saudi Arabia Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 270. Israel Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 271. UAE Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 272. Turkey Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 273. Iran Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 274. Egypt Meropenem Injection Revenue (2021-2032) & (US$ Million) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Meropenem Injection Distributors List Table 278. Meropenem Injection Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Meropenem Injection Image Figure 2. Global Meropenem Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.25g/vial Image Figure 5. 0.5g/vial Image Figure 6. 1g/vial Image Figure 7. Global Meropenem Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Meropenem Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Meropenem Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Meropenem Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Meropenem Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Meropenem Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Meropenem Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Meropenem Injection Sales (2021-2032) & (K Units) Figure 18. Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Meropenem Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Meropenem Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Meropenem Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Meropenem Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Meropenem Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Meropenem Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Meropenem Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Meropenem Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Meropenem Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Meropenem Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Meropenem Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Meropenem Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Meropenem Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Meropenem Injection Sales Market Share by Type (2021-2032) Figure 34. Global Meropenem Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Meropenem Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Meropenem Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Meropenem Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Meropenem Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Meropenem Injection Sales Market Share by Application (2021-2032) Figure 40. North America Meropenem Injection Revenue Share by Type (2021-2032) Figure 41. North America Meropenem Injection Sales Share by Type (2021-2032) Figure 42. North America Meropenem Injection Revenue Share by Application (2021-2032) Figure 43. North America Meropenem Injection Sales Share by Application (2021-2032) Figure 44. North America Meropenem Injection Revenue Share by Country (2021-2032) Figure 45. North America Meropenem Injection Sales Share by Country (2021-2032) Figure 46. Europe Meropenem Injection Revenue Share by Type (2021-2032) Figure 47. Europe Meropenem Injection Sales Share by Type (2021-2032) Figure 48. Europe Meropenem Injection Revenue Share by Application (2021-2032) Figure 49. Europe Meropenem Injection Sales Share by Application (2021-2032) Figure 50. Europe Meropenem Injection Revenue Share by Country (2021-2032) Figure 51. Europe Meropenem Injection Sales Share by Country (2021-2032) Figure 52. China Meropenem Injection Revenue Share by Type (2021-2032) Figure 53. China Meropenem Injection Sales Share by Type (2021-2032) Figure 54. China Meropenem Injection Revenue Share by Application (2021-2032) Figure 55. China Meropenem Injection Sales Share by Application (2021-2032) Figure 56. Asia Meropenem Injection Revenue Share by Type (2021-2032) Figure 57. Asia Meropenem Injection Sales Share by Type (2021-2032) Figure 58. Asia Meropenem Injection Revenue Share by Application (2021-2032) Figure 59. Asia Meropenem Injection Sales Share by Application (2021-2032) Figure 60. Asia Meropenem Injection Revenue Share by Country (2021-2032) Figure 61. Asia Meropenem Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Meropenem Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Meropenem Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Meropenem Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Meropenem Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Meropenem Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Meropenem Injection Sales Share by Country (2021-2032) Figure 68. Meropenem Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Meropenem Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g/vial
  • 0.5g/vial
  • 1g/vial
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Chongqin Shenghuaxi
  • Zhejiang Hisun Pharmaceutical
  • Xinya Pharm
  • CSPC Group
  • Shenzhen Haibin Pharmaceutical
  • Sandoz
  • Mylan
  • Luoxin Pharmaceutical
  • United Laboratories
  • Pfizer
  • Hainan Haiyao Co., Ltd.
  • Fresenius Kabi
  • PKU HealthCare
  • Sumitomo Dainippon Pharma
  • Sagent Pharmaceuticals
  • Macleods Pharmaceuticals
  • Johnlee Pharmaceuticals
  • Bionova Scientific
  • AuroMedics
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Meropenem Injection Market by Type
  3. 1.2.1 Global Meropenem Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.25g/vial
  5. 1.2.3 0.5g/vial
  6. 1.2.4 1g/vial
  7. 1.3 Meropenem Injection Market by Application
  8. 1.3.1 Global Meropenem Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinics
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Meropenem Injection Market Dynamics
  1. 2.1 Meropenem Injection Industry Trends
  2. 2.2 Meropenem Injection Industry Drivers
  3. 2.3 Meropenem Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Meropenem Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Meropenem Injection Revenue by Region
  3. 3.2.1 Global Meropenem Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Meropenem Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Meropenem Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Meropenem Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Meropenem Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Meropenem Injection Sales by Region
  9. 3.4.1 Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Meropenem Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Meropenem Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Meropenem Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Meropenem Injection Revenue by Manufacturers
  2. 4.1.1 Global Meropenem Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Meropenem Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Meropenem Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Meropenem Injection Sales by Manufacturers
  6. 4.2.1 Global Meropenem Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Meropenem Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Meropenem Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Meropenem Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Meropenem Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Meropenem Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Meropenem Injection Manufacturers, Product Type & Application
  13. 4.7 Global Meropenem Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Meropenem Injection Market CR5 and HHI
  16. 4.8.2 2025 Meropenem Injection Tier 1, Tier 2, and Tier 3
5 Meropenem Injection Market by Type
  1. 5.1 Global Meropenem Injection Revenue by Type
  2. 5.1.1 Global Meropenem Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Meropenem Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Meropenem Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Meropenem Injection Sales by Type
  6. 5.2.1 Global Meropenem Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meropenem Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Meropenem Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Meropenem Injection Price by Type
6 Meropenem Injection Market by Application
  1. 6.1 Global Meropenem Injection Revenue by Application
  2. 6.1.1 Global Meropenem Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Meropenem Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Meropenem Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Meropenem Injection Sales by Application
  6. 6.2.1 Global Meropenem Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Meropenem Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Meropenem Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Meropenem Injection Price by Application
7 Company Profiles
  1. 7.1 Chongqin Shenghuaxi
  2. 7.1.1 Chongqin Shenghuaxi Company Information
  3. 7.1.2 Chongqin Shenghuaxi Business Overview
  4. 7.1.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
  6. 7.1.5 Chongqin Shenghuaxi Recent Developments
  7. 7.2 Zhejiang Hisun Pharmaceutical
  8. 7.2.1 Zhejiang Hisun Pharmaceutical Company Information
  9. 7.2.2 Zhejiang Hisun Pharmaceutical Business Overview
  10. 7.2.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
  12. 7.2.5 Zhejiang Hisun Pharmaceutical Recent Developments
  13. 7.3 Xinya Pharm
  14. 7.3.1 Xinya Pharm Company Information
  15. 7.3.2 Xinya Pharm Business Overview
  16. 7.3.3 Xinya Pharm Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xinya Pharm Meropenem Injection Product Portfolio
  18. 7.3.5 Xinya Pharm Recent Developments
  19. 7.4 CSPC Group
  20. 7.4.1 CSPC Group Company Information
  21. 7.4.2 CSPC Group Business Overview
  22. 7.4.3 CSPC Group Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSPC Group Meropenem Injection Product Portfolio
  24. 7.4.5 CSPC Group Recent Developments
  25. 7.5 Shenzhen Haibin Pharmaceutical
  26. 7.5.1 Shenzhen Haibin Pharmaceutical Company Information
  27. 7.5.2 Shenzhen Haibin Pharmaceutical Business Overview
  28. 7.5.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
  30. 7.5.5 Shenzhen Haibin Pharmaceutical Recent Developments
  31. 7.6 Sandoz
  32. 7.6.1 Sandoz Company Information
  33. 7.6.2 Sandoz Business Overview
  34. 7.6.3 Sandoz Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz Meropenem Injection Product Portfolio
  36. 7.6.5 Sandoz Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Meropenem Injection Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Luoxin Pharmaceutical
  44. 7.8.1 Luoxin Pharmaceutical Company Information
  45. 7.8.2 Luoxin Pharmaceutical Business Overview
  46. 7.8.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
  48. 7.8.5 Luoxin Pharmaceutical Recent Developments
  49. 7.9 United Laboratories
  50. 7.9.1 United Laboratories Company Information
  51. 7.9.2 United Laboratories Business Overview
  52. 7.9.3 United Laboratories Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 United Laboratories Meropenem Injection Product Portfolio
  54. 7.9.5 United Laboratories Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Meropenem Injection Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 Hainan Haiyao Co., Ltd.
  62. 7.11.1 Hainan Haiyao Co., Ltd. Company Information
  63. 7.11.2 Hainan Haiyao Co., Ltd. Business Overview
  64. 7.11.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
  66. 7.11.5 Hainan Haiyao Co., Ltd. Recent Developments
  67. 7.12 Fresenius Kabi
  68. 7.12.1 Fresenius Kabi Company Information
  69. 7.12.2 Fresenius Kabi Business Overview
  70. 7.12.3 Fresenius Kabi Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Fresenius Kabi Meropenem Injection Product Portfolio
  72. 7.12.5 Fresenius Kabi Recent Developments
  73. 7.13 PKU HealthCare
  74. 7.13.1 PKU HealthCare Company Information
  75. 7.13.2 PKU HealthCare Business Overview
  76. 7.13.3 PKU HealthCare Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 PKU HealthCare Meropenem Injection Product Portfolio
  78. 7.13.5 PKU HealthCare Recent Developments
  79. 7.14 Sumitomo Dainippon Pharma
  80. 7.14.1 Sumitomo Dainippon Pharma Company Information
  81. 7.14.2 Sumitomo Dainippon Pharma Business Overview
  82. 7.14.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
  84. 7.14.5 Sumitomo Dainippon Pharma Recent Developments
  85. 7.15 Sagent Pharmaceuticals
  86. 7.15.1 Sagent Pharmaceuticals Company Information
  87. 7.15.2 Sagent Pharmaceuticals Business Overview
  88. 7.15.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
  90. 7.15.5 Sagent Pharmaceuticals Recent Developments
  91. 7.16 Macleods Pharmaceuticals
  92. 7.16.1 Macleods Pharmaceuticals Company Information
  93. 7.16.2 Macleods Pharmaceuticals Business Overview
  94. 7.16.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
  96. 7.16.5 Macleods Pharmaceuticals Recent Developments
  97. 7.17 Johnlee Pharmaceuticals
  98. 7.17.1 Johnlee Pharmaceuticals Company Information
  99. 7.17.2 Johnlee Pharmaceuticals Business Overview
  100. 7.17.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
  102. 7.17.5 Johnlee Pharmaceuticals Recent Developments
  103. 7.18 Bionova Scientific
  104. 7.18.1 Bionova Scientific Company Information
  105. 7.18.2 Bionova Scientific Business Overview
  106. 7.18.3 Bionova Scientific Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bionova Scientific Meropenem Injection Product Portfolio
  108. 7.18.5 Bionova Scientific Recent Developments
  109. 7.19 AuroMedics
  110. 7.19.1 AuroMedics Company Information
  111. 7.19.2 AuroMedics Business Overview
  112. 7.19.3 AuroMedics Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 AuroMedics Meropenem Injection Product Portfolio
  114. 7.19.5 AuroMedics Recent Developments
  115. 7.20 Amneal Pharmaceuticals
  116. 7.20.1 Amneal Pharmaceuticals Company Information
  117. 7.20.2 Amneal Pharmaceuticals Business Overview
  118. 7.20.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
  120. 7.20.5 Amneal Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Meropenem Injection Market Size by Type
  2. 8.1.1 North America Meropenem Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Meropenem Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Meropenem Injection Price by Type (2021-2032)
  5. 8.2 North America Meropenem Injection Market Size by Application
  6. 8.2.1 North America Meropenem Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Meropenem Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Meropenem Injection Price by Application (2021-2032)
  9. 8.3 North America Meropenem Injection Market Size by Country
  10. 8.3.1 North America Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Meropenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Meropenem Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Meropenem Injection Market Size by Type
  2. 9.1.1 Europe Meropenem Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Meropenem Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Meropenem Injection Price by Type (2021-2032)
  5. 9.2 Europe Meropenem Injection Market Size by Application
  6. 9.2.1 Europe Meropenem Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Meropenem Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Meropenem Injection Price by Application (2021-2032)
  9. 9.3 Europe Meropenem Injection Market Size by Country
  10. 9.3.1 Europe Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Meropenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Meropenem Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Meropenem Injection Market Size by Type
  2. 10.1.1 China Meropenem Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Meropenem Injection Sales by Type (2021-2032)
  4. 10.1.3 China Meropenem Injection Price by Type (2021-2032)
  5. 10.2 China Meropenem Injection Market Size by Application
  6. 10.2.1 China Meropenem Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Meropenem Injection Sales by Application (2021-2032)
  8. 10.2.3 China Meropenem Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Meropenem Injection Market Size by Type
  2. 11.1.1 Asia Meropenem Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Meropenem Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Meropenem Injection Price by Type (2021-2032)
  5. 11.2 Asia Meropenem Injection Market Size by Application
  6. 11.2.1 Asia Meropenem Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Meropenem Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Meropenem Injection Price by Application (2021-2032)
  9. 11.3 Asia Meropenem Injection Market Size by Country
  10. 11.3.1 Asia Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Meropenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Meropenem Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Meropenem Injection Market Size by Type
  2. 12.1.1 SAMEA Meropenem Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Meropenem Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Meropenem Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Meropenem Injection Market Size by Application
  6. 12.2.1 SAMEA Meropenem Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Meropenem Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Meropenem Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Meropenem Injection Market Size by Country
  10. 12.3.1 SAMEA Meropenem Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Meropenem Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Meropenem Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Meropenem Injection Value Chain Analysis
  2. 13.1.1 Meropenem Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Meropenem Injection Production Mode & Process
  6. 13.2 Meropenem Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Meropenem Injection Distributors
  9. 13.2.3 Meropenem Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst